{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T06:23:27Z","timestamp":1744093407896},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,4,12]],"date-time":"2014-04-12T00:00:00Z","timestamp":1397260800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s40292-014-0052-5","type":"journal-article","created":{"date-parts":[[2014,4,11]],"date-time":"2014-04-11T21:27:34Z","timestamp":1397251654000},"page":"221-226","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Berberine and Monacolin Effects on the Cardiovascular Risk Profile of Women with Oestroprogestin-Induced Hypercholesterolemia"],"prefix":"10.1007","volume":"21","author":[{"given":"Arrigo F. G.","family":"Cicero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Reggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Parini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martino","family":"Morbini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Rosticci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Grandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,12]]},"reference":[{"issue":"5","key":"52_CR1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","volume":"83","author":"J Trussell","year":"2011","unstructured":"Trussell J. Contraceptive failure in the United States. Contraception. 2011;83(5):397\u2013404.","journal-title":"Contraception"},{"issue":"3","key":"52_CR2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1517\/14656566.2013.767334","volume":"14","author":"I Streuli","year":"2013","unstructured":"Streuli I, de Ziegler D, Santulli P, Marcellin L, Borghese B, Batteux F, Chapron C. An update on the pharmacological management of endometriosis. Expert Opin Pharmacother. 2013;14(3):291\u2013305.","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"52_CR3","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89(6):2745\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"52_CR4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1742-1241.2008.01877.x","volume":"63","author":"GM Soares","year":"2009","unstructured":"Soares GM, Vieira CS, de Paula Martins W, Dos Reis RM, de S\u00e1 MF, Ferriani RA. Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome. Int J Clin Pract. 2009;63(1):160\u20139.","journal-title":"Int J Clin Pract"},{"issue":"7\u20138","key":"52_CR5","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1177\/106002809502907-817","volume":"29","author":"B Kaplan","year":"1995","unstructured":"Kaplan B. Desogestrel, norgestimate, and gestodene: the newer progestins. Ann Pharmacother. 1995;29(7\u20138):736\u201342.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"52_CR6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.contraception.2009.07.011","volume":"81","author":"I Wiegratz","year":"2010","unstructured":"Wiegratz I, Stahlberg S, Manthey T, S\u00e4nger N, Mittmann K, Palombo-Kinne E, Mellinger U, Lange E, Kuhl H. Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on lipid metabolism during 1 year of conventional or extended-cycle use. Contraception. 2010;81(1):57\u201361.","journal-title":"Contraception"},{"issue":"2","key":"52_CR7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.contraception.2010.11.002","volume":"84","author":"FA Barreiros","year":"2011","unstructured":"Barreiros FA, Guazzelli CAF, Barbosa R, Torloni MR, Barbieri M, Araujo FF. Extended regimens of the combined contraceptive vaginal ring containing etonogestrel and ethinyl estradiol: effects on lipid metabolism. Contraception. 2011;84(2):155\u20139.","journal-title":"Contraception"},{"issue":"15","key":"52_CR8","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1056\/NEJM198304143081502","volume":"308","author":"P Wahl","year":"1983","unstructured":"Wahl P, Walden C, Knopp R, Hoover J, Wallace R, Heiss G, Rifkind B. Effect of estrogen\/progestin potency on lipid\/lipoprotein cholesterol. N Engl J Med. 1983;308(15):862\u20137.","journal-title":"N Engl J Med"},{"issue":"20","key":"52_CR9","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJM199011153232003","volume":"323","author":"I Godsland","year":"1990","unstructured":"Godsland I, Crook D, Simpson R, Proudler T, Felton C, Lees B, Anyaoku V, Devenport M, Wynn V. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med. 1990;323(20):1375\u201381.","journal-title":"N Engl J Med"},{"issue":"6 Pt 2","key":"52_CR10","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/0002-9378(88)90199-8","volume":"158","author":"D Crook","year":"1988","unstructured":"Crook D, Godsland IF, Wynn V. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins. Am J Obstet Gynecol. 1988;158(6 Pt 2):1612\u201320.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"52_CR11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.contraception.2003.10.004","volume":"69","author":"H Scharnagl","year":"2004","unstructured":"Scharnagl H, Petersen G, Nauck M, Teichmann AT, Wieland H, M\u00e4rz W. Double-blind, randomized study comparing the effects of two monophasic oral contraceptives containing ethinylestradiol (20 microg or 30 microg) and levonorgestrel (100 microg or 150 microg) on lipoprotein metabolism. Contraception. 2004;69(2):105\u201313.","journal-title":"Contraception"},{"issue":"6","key":"52_CR12","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3109\/13625187.2011.604450","volume":"16","author":"UM \u00c5gren","year":"2011","unstructured":"\u00c5gren UM, Anttila M, M\u00e4enp\u00e4\u00e4-Liukko K, Rantala ML, Rautiainen H, Sommer WF, Mommers E. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17\u03b2-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism. Eur J Contracept Reprod Health Care. 2011;16(6):444\u201357.","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"3","key":"52_CR13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0010-7824(98)00018-3","volume":"57","author":"D Crook","year":"1998","unstructured":"Crook D, Godsland I. Safety evaluation of modern oral contraceptives. Effects on lipoprotein and carbohydrate metabolism. Contraception. 1998;57(3):189\u2013201.","journal-title":"Contraception"},{"key":"52_CR14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/1876526201305010018","volume":"5","author":"AFG Cicero","year":"2013","unstructured":"Cicero AFG, Parini A, Rosticci M, Brancaleoni B, Derosa G, Grandi E, Borghi C. Effect of a lipid-lowering nutraceutical on pulse-wave-velocity in hypercholesterolemic patients with or without chronic kidney disease. Open Hypertens J. 2013;5:18\u201322.","journal-title":"Open Hypertens J"},{"issue":"1","key":"52_CR15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.atherosclerosis.2011.06.028","volume":"217","author":"AL Catapano","year":"2011","unstructured":"Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund O, et al. ESC Committee for Practice Guidelines 2008\u20132010 and 2010\u20132012 Committees. ESC\/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis. 2011;217(1):3\u201346.","journal-title":"Atherosclerosis"},{"issue":"1","key":"52_CR16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group","year":"2004","unstructured":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41\u20137.","journal-title":"Hum Reprod"},{"issue":"7","key":"52_CR17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139.","journal-title":"Diabetologia"},{"issue":"12","key":"52_CR18","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1093\/clinchem\/45.12.2136","volume":"45","author":"N Rifai","year":"1999","unstructured":"Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high-sensitivity c-reactive protein assay. Clin Chem. 1999;45(12):2136\u201341.","journal-title":"Clin Chem"},{"issue":"5","key":"52_CR19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2217\/clp.12.55","volume":"7","author":"AFG Cicero","year":"2012","unstructured":"Cicero AFG, Tartagni E, Borghi C. Nutraceuticals with lipid-lowering activity: do they have any effect beyond cholesterol reduction? J Clin Lipid. 2012;7(5):549\u201359.","journal-title":"J Clin Lipid"},{"issue":"2","key":"52_CR20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12349-010-0043-6","volume":"4","author":"B Trimarco","year":"2011","unstructured":"Trimarco B, Benvenuti C, Rozza F, Cimmino CS, Giudice R, Crispo S. Clinical evidence of efficacy of red yeast rice and berberine in a large controlled study versus diet. Med J Nutr Metab. 2011;4(2):133\u20139.","journal-title":"Med J Nutr Metab"},{"key":"52_CR21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1476-511X-11-123","volume":"11","author":"L Pisciotta","year":"2012","unstructured":"Pisciotta L, Bellocchio A, Bertolini S. Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment. Lipids Health Dis. 2012;11:123.","journal-title":"Lipids Health Dis"},{"issue":"12","key":"52_CR22","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s12325-011-0082-5","volume":"28","author":"G Marazzi","year":"2011","unstructured":"Marazzi G, Cacciotti L, Pelliccia F, Iaia L, Volterrani M, Caminiti G, Sposato B, Massaro R, Grieco F, Rosano G. Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients. Adv Ther. 2011;28(12):1105\u201313.","journal-title":"Adv Ther"},{"issue":"10","key":"52_CR23","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.amjcard.2010.01.337","volume":"105","author":"AFG Cicero","year":"2010","unstructured":"Cicero AFG, Derosa G, Borghi C. Red yeast rice and statin-intolerant patients. Am J Cardiol. 2010;105(10):1504.","journal-title":"Am J Cardiol"},{"issue":"5","key":"52_CR24","first-page":"431","volume":"64","author":"M Zanardi","year":"2012","unstructured":"Zanardi M, Quirico E, Benvenuti C, Pezzana A. Use of a lipid-lowering food supplement in patients on hormone therapy following breast cancer. Minerva Ginecol. 2012;64(5):431\u20135.","journal-title":"Minerva Ginecol"},{"issue":"2","key":"52_CR25","first-page":"15","volume":"11","author":"AFG Cicero","year":"2012","unstructured":"Cicero AFG, De Sando V, Benedetto D, Cevenini M, Grandi E, Borghi C. Long-term efficacy and tolerability of a largely marketed multicomponent nutraceutical in overweight and normoweight dyslipidaemic patients. Nutrafoods. 2012;11(2):15\u201321.","journal-title":"Nutrafoods"},{"issue":"9","key":"52_CR26","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.numecd.2009.05.017","volume":"20","author":"F Affuso","year":"2010","unstructured":"Affuso F, Ruvolo A, Micillo F, Sacc\u00e0 L, Fazio S. Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study. Nutr Metab Cardiovasc Dis. 2010;20(9):656\u201361.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"52_CR27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/jwh.2010.2053","volume":"20","author":"DW Stovall","year":"2011","unstructured":"Stovall DW, Bailey AP, Pastore LM. Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome. J Womens Health. 2011;20(1):37\u201343.","journal-title":"J Womens Health"},{"issue":"3","key":"52_CR28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4330\/wjc.v4.i3.77","volume":"4","author":"F Affuso","year":"2012","unstructured":"Affuso F, Mercurio V, Ruvolo A, Pirozzi C, Micillo F, Carlomagno G, Grieco F, Fazio S. A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome. World J Cardiol. 2012;4(3):77\u201383.","journal-title":"World J Cardiol"},{"issue":"1","key":"52_CR29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1530\/EJE-11-0616","volume":"166","author":"W Wei","year":"2012","unstructured":"Wei W, Zhao H, Wang A, Sui M, Liang K, Deng H, Ma Y, Zhang Y, Zhang H, Guan Y. A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome. Eur J Endocrinol. 2012;166(1):99\u2013105.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"52_CR30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijgo.2007.06.005","volume":"99","author":"H Meden-Vrtovec","year":"2007","unstructured":"Meden-Vrtovec H, Vrtovec B, Osredkar J. Metabolic and cardiovascular changes in women with polycystic ovary syndrome. Int J Gynaecol Obstet. 2007;99(2):87\u201390.","journal-title":"Int J Gynaecol Obstet"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-014-0052-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40292-014-0052-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-014-0052-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T17:16:39Z","timestamp":1597684599000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40292-014-0052-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,12]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["52"],"URL":"https:\/\/doi.org\/10.1007\/s40292-014-0052-5","relation":{},"ISSN":["1120-9879","1179-1985"],"issn-type":[{"value":"1120-9879","type":"print"},{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,12]]}}}